
Health
FDA approves first-ever AI glucose monitor for weight loss from Signos
The Food and Drug Administration (FDA) has approved the first-ever glucose monitoring system designed specifically for weight loss, developed by health-tech startup Signos. The decision, announced Wednesday, creates a new pathway for Americans seeking to manage their weight outside of traditional treatments like medication or surgery. A New Option Beyond